Literature DB >> 10823801

Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations.

F Remoué1, F Rogerie, M C Gallissot, H L Guyatt, J L Neyrinck, M M Diakkhate, M Niang, A E Butterworth, C Auriault, A Capron, G Riveau.   

Abstract

The reduction of Schistosoma fecundity observed after experimental vaccination with the Schistosoma mansoni 28-kDa glutathione S-transferase (Sm28GST) antigen has been related to the inhibition of glutathione S-transferase (GST) enzymatic activity by specific antibody. The humoral immune response to the protective antigen Sm28GST and to the epitopes involved in the enzymatic site (amino acid ¿aa sequences 10-43 and 190-211) was evaluated in infected individuals before chemotherapy treatment. The capacity of the serum samples to inhibit GST enzymatic activity was assessed. Specific IgG3 response was predominant in the male population with a low intensity of infection and was associated with maximal GST inhibition. In contrast, the neutralizing activity of serum samples from women with a low intensity of infection was correlated with high specific IgA response specifically directed toward the 190-211 epitope. These results strongly support the hypothesis that GST-neutralizing IgG3 and IgA isotypes are sex dependent. The relationship of this specific acquired immune response with the level of intensity of infection is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823801     DOI: 10.1086/315454

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Gender-dependent specific immune response during chronic human Schistosomiasis haematobia.

Authors:  F Remoué; D To Van; A M Schacht; M Picquet; O Garraud; J Vercruysse; A Ly; A Capron; G Riveau
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Functional specific binding of testosterone to Schistosoma haematobium 28-kilodalton glutathione S-transferase.

Authors:  Franck Remoué; Jean-Claude Mani; Martine Pugnière; Anne-Marie Schacht; André Capron; Gilles Riveau
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Gene Expression Differences in Host Response to Schistosoma haematobium Infection.

Authors:  Kathryn M Dupnik; Mary Juliet Reust; Kaitlin M Vick; Benjamin Yao; Donald Miyaye; Eric Lyimo; Crispin Mukerebe; Julius Mngara; Samuel E Kalluvya; Claudia J de Dood; Paul L A M Corstjens; Govert J van Dam; Tuo Zhang; Jenny Xiang; Myung Hee Lee; Jennifer A Downs
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

4.  HLA class II polymorphism influences onset and severity of pathology in Schistosoma mansoni-infected transgenic mice.

Authors:  G Angyalosi; R Neveu; I Wolowczuk; A Delanoye; J Herno; C Auriault; V Pancré
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Recent Advances in Schistosomiasis.

Authors:  G. Richard Olds; Srinivasan Dasarathy
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

6.  Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential.

Authors:  Kakuturu V N Rao; Yi-Xun He; Ramaswamy Kalyanasundaram
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

7.  Schistosoma mansoni infection in a rural area of the Jequitinhonha Valley, Minas Gerais, Brazil: analysis of exposure risk.

Authors:  Wesley Rodrigues Pereira; Helmut Kloos; Sara B Crawford; Jorge Gustavo Velásquez-Melendez; Leonardo Ferreira Matoso; Ricardo Toshio Fujiwara; Guilherme Grossi Lopes Cançado; Philip T Loverde; Rodrigo Correa-Oliveira; Andrea Gazzinelli
Journal:  Acta Trop       Date:  2009-09-16       Impact factor: 3.112

8.  Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies.

Authors:  G L Palmisano; P L Tazzari; E Cozzi; A Bolognesi; L Polito; M Seveso; E Ancona; F Ricci; R Conte; F Stirpe; G B Ferrara; M P Pistillo
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 9.  Helminth infections and allergic diseases: from the Th2 paradigm to regulatory networks.

Authors:  André Capron; David Dombrowicz; Monique Capron
Journal:  Clin Rev Allergy Immunol       Date:  2004-02       Impact factor: 8.667

10.  Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial.

Authors:  Robert Tweyongyere; Patrice A Mawa; Sophy Ngom-Wegi; Juliet Ndibazza; Trinh Duong; Birgitte J Vennervald; David W Dunne; Eli Katunguka-Rwakishaya; Alison M Elliott
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.